Jefferies Financial Group Inc. Esperion Therapeutics, Inc. Call Options Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$1.84 - $3.24 $184,000 - $324,000
100,000 New
100,000 $222,000
Q1 2023

May 15, 2023
SELL
$1.46 - $7.3 $99,280 - $496,400
-68,000 Reduced 57.63%
50,000 $79,000
Q4 2022

Sep 21, 2023
BUY
$5.09 - $8.5 $346,120 - $578,000
68,000 Added 136.0%
118,000 $735,000
Q4 2022

Feb 14, 2023
BUY
$5.09 - $8.5 $600,620 - $1 Million
118,000 New
118,000 $735,000

Others Institutions Holding ESPR

# of Institutions
206
Shares Held
129M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $147M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email